Related Experiment Video
Updated: Sep 10, 2025

Simultaneous Laryngopharyngeal and Conventional Esophageal pH Monitoring
Published on: December 14, 2020
Sporadic Fundic Gland Polyposis Associated With Long-Term Proton Pump Inhibitor Use: A Case Report
1Gastroenterology, Sengkang General Hospital, Singapore, SGP.
Abstract:
Fundic gland polyps (FGPs) are the most common type of gastric polyps and are frequently discovered incidentally during upper endoscopy. Long-term use of proton pump inhibitors (PPIs) has been associated with an increased risk of developing FGPs. We present a case of PPI-induced FGP in a 78-year-old woman who had been taking omeprazole daily for 15 years and was referred for evaluation of anemia. Gastroscopy revealed innumerable FGPs in the gastric body. Histological analysis demonstrated dilated glands within the fundic mucosa, consistent with FGPs. These polyps are typically small and benign and located in the gastric corpus and fundus. While FGPs are generally non-neoplastic, discontinuation of PPI therapy should be considered on a case-by-case basis. Indications for long-term PPI use should be regularly assessed. Unnecessary PPI therapy should be discontinued when appropriate.
More Related Videos
Related Concept Videos
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Injurious Factors
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
Acid Suppressive Drugs for Peptic Ulcer Disease: Histamine H2-Receptor Antagonists

